These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 28063664)
1. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma. Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664 [TBL] [Abstract][Full Text] [Related]
2. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models. Ferreira de Oliveira JMP; Pacheco AR; Coutinho L; Oliveira H; Pinho S; Almeida L; Fernandes E; Santos C Arch Toxicol; 2018 Mar; 92(3):1205-1214. PubMed ID: 29270805 [TBL] [Abstract][Full Text] [Related]
3. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway. Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951 [TBL] [Abstract][Full Text] [Related]
4. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Hahn SM; Liebmann JE; Cook J; Fisher J; Goldspiel B; Venzon D; Mitchell JB; Kaufman D Cancer; 1993 Nov; 72(9):2705-11. PubMed ID: 8104682 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines. Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388 [TBL] [Abstract][Full Text] [Related]
6. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530 [TBL] [Abstract][Full Text] [Related]
7. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines. Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709 [TBL] [Abstract][Full Text] [Related]
8. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways. Alshatwi AA; Ramesh E; Periasamy VS; Subash-Babu P Fundam Clin Pharmacol; 2013 Dec; 27(6):581-92. PubMed ID: 22913657 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Badinloo M; Esmaeili-Mahani S Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575 [TBL] [Abstract][Full Text] [Related]
10. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Adan A; Baran Y Tumour Biol; 2016 May; 37(5):5781-95. PubMed ID: 26408178 [TBL] [Abstract][Full Text] [Related]
11. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide]. Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662 [TBL] [Abstract][Full Text] [Related]
12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression. Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093 [TBL] [Abstract][Full Text] [Related]
13. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents. Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574 [TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells. Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517 [TBL] [Abstract][Full Text] [Related]
16. The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity. Prabhu NS; Somasundaram K; Tian H; Enders GH; Satyamoorthy K; Herlyn M; El-Deiry WS Int J Oncol; 1999 Aug; 15(2):209-16. PubMed ID: 10402229 [TBL] [Abstract][Full Text] [Related]
17. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Schwartz CL; Wexler LH; Krailo MD; Teot LA; Devidas M; Steinherz LJ; Goorin AM; Gebhardt MC; Healey JH; Sato JK; Meyers PA; Grier HE; Bernstein ML; Lipshultz SE Pediatr Blood Cancer; 2016 Jan; 63(1):54-61. PubMed ID: 26398490 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells. Jia SF; Zwelling LA; McWatters A; An T; Kleinerman ES J Exp Ther Oncol; 2002; 2(1):27-36. PubMed ID: 12415617 [TBL] [Abstract][Full Text] [Related]
19. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells. Zhu JJ; Li FB; Zhu XF; Liao WM Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212 [TBL] [Abstract][Full Text] [Related]
20. Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest. Li Z; Yu Y; Sun S; Qi B; Wang W; Yu A Oncol Rep; 2015 Apr; 33(4):1763-8. PubMed ID: 25634333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]